94 results on '"Magnano, C."'
Search Results
2. Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease
- Author
-
Beggs, CB, Magnano, C, Shepherd, SJ, Belov, P, Ramasamy, DP, Hagemeier, J, and Zivadinov, R
- Abstract
Aging of the healthy brain is characterized by focal or nonfocal white matter (WM) signal abnormality (SA) changes, which are typically detected as leukoaraiosis (LA). Hypertension is a risk factor for WM lesion formation. This study investigated whether LA might be associated with increased cerebrospinal fluid (CSF) pulsatility linked to arterial hypertension.A total of 101 individuals without neurologic diseases (53 females and 48 males) aged between 18 and 75 years underwent 3T brain MRI with cine phase contrast imaging for CSF flow estimation, after providing their informed consent. LA was defined as the presence of focal T2 WM SA changes and/or nonfocal uniform areas of signal increase termed dirty appearing white matter (DAWM). Relevant information relating to cardiovascular risk factors was also collected.When controlled for age and hypertension, significant partial correlations were observed between: DAWM volume and: net negative flow (r = -.294, P = .014); net positive flow (NPF) (r = .406, P = .001); and peak positive velocity (r = .342, P = .004). Multiple linear regression analysis revealed DAWM volume to be significantly correlated with CSF NPF (P = .019) and hypertension (P = .007), whereas T2 WM SA volume was only significantly correlated with age (P = .002). Combined DAWM and T2 WM SA volumes were significantly related with age (P = .001) and CSF peak negative velocity (P = .041).Rarefaction of WM leading to LA is a multifactorial process, in which formation of DAWM induced by hypertension and increased aqueductal CSF pulsatility, may play a contributory role. These two factors appear to act independently of each other in a process that is independent of age.
- Published
- 2016
3. Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis
- Author
-
Belov, P., primary, Jakimovski, D., additional, Krawiecki, J., additional, Magnano, C., additional, Hagemeier, J., additional, Pelizzari, L., additional, Weinstock-Guttman, B., additional, and Zivadinov, R., additional
- Published
- 2017
- Full Text
- View/download PDF
4. Internal jugular vein cross-sectional area and cerebrospinal fluid pulsatility in the aqueduct of Sylvius
- Author
-
Beggs, CB, Magnano, C, Belov, P, Krawiecki, J, Ramasamy, DP, Hagemeier, J, and Zivadinov, R
- Published
- 2015
5. Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients
- Author
-
Beggs, CB, Magnano, C, Belov, P, Krawiecki, J, Ramasamy, DP, Hagemeier, J, Zivadinov, R, Beggs, CB, Magnano, C, Belov, P, Krawiecki, J, Ramasamy, DP, Hagemeier, J, and Zivadinov, R
- Abstract
Objectives Constricted cerebral venous outflow has been linked with increased cerebrospinal fluid (CSF) pulsatility in the aqueduct of Sylvius in multiple sclerosis (MS) patients and healthy individuals. This study investigates the relationship between CSF pulsatility and internal jugular vein (IJV) cross-sectional area (CSA) in these two groups, something previously unknown. Methods 65 relapsing-remitting MS patients (50.8% female; mean age = 43.8 years) and 74 healthy controls (HCs) (54.1% female; mean age = 43.9 years) were investigated. CSF flow quantification was performed on cine phase-contrast MRI, while IJV-CSA was calculated using magnetic resonance venography. Statistical analysis involved correlation, and partial least squares correlation analysis (PLSCA). Results PLSCA revealed a significant difference (p<0.001; effect size = 1.072) between MS patients and HCs in the positive relationship between CSF pulsatility and IJV-CSA at C5-T1, something not detected at C2-C4. Controlling for age and cardiovascular risk factors, statistical trends were identified in HCs between: increased net positive CSF flow (NPF) and increased IJV-CSA at C5-C6 (left: r = 0.374, p = 0.016; right: r = 0.364, p = 0.019) and C4 (left: r = 0.361, p = 0.020); and increased net negative CSF flow and increased left IJV-CSA at C5-C6 (r = -0.348, p = 0.026) and C4 (r = -0.324, p = 0.039), whereas in MS patients a trend was only identified between increased NPF and increased left IJV-CSA at C5-C6 (r = 0.351, p = 0.021). Overall, correlations were weaker in MS patients (p = 0.015). Conclusions In healthy adults, increased CSF pulsatility is associated with increased IJV-CSA in the lower cervix (independent of age and cardiovascular risk factors), suggesting a biomechanical link between the two. This relationship is altered in MS patients.
- Published
- 2016
6. Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals.
- Author
-
Magnano, C, Belov, P, Krawiecki, J, Hagemeier, J, Beggs, CB, Zivadinov, R, Magnano, C, Belov, P, Krawiecki, J, Hagemeier, J, Beggs, CB, and Zivadinov, R
- Abstract
Internal jugular vein (IJV) narrowing has been implicated in central nervous system pathologies, however normal physiological age- and gender-related IJV variance in healthy individuals (HIs) has not been adequately assessed.We assessed the relationship between IJV cross-sectional area (CSA) and aging.This study involved 193 HIs (63 males and 130 females) who received 2-dimensional magnetic resonance venography at 3T. The minimum CSA of the IJVs at cervical levels C2/C3, C4, C5/C6, and C7/T1 was obtained using a semi-automated contouring-thresholding technique. Subjects were grouped by decade. Pearson and partial correlation (controlled for cardiovascular risk factors, including hypertension, heart disease, smoking and body mass index) and analysis of variance analyses were used, with paired t-tests comparing side differences.Mean right IJV CSA ranges were: in males, 41.6 mm2 (C2/C3) to 82.0 mm2 (C7/T1); in females, 38.0 mm2 (C2/C3) to 62.3 mm2 (C7/T1), while the equivalent left side ranges were: in males, 28.0 mm2 (C2/C3) to 52.2 mm2 (C7/T1); in females, 27.2 mm2 (C2/C3) to 47.8 mm2 (C7/T1). The CSA of the right IJVs was significantly larger (p<0.001) than the left at all cervical levels. Controlling for cardiovascular risk factors, the correlation between age and IJV CSA was more robust in males than in the females for all cervical levels.In HIs age, gender, hand side and cervical location all affect IJV CSA. These findings suggest that any definition of IJV stenosis needs to account for these factors.
- Published
- 2016
7. Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease.
- Author
-
Belov, P, Magnano, C, Krawiecki, J, Hagemeier, J, Bergsland, N, Beggs, CB, Zivadinov, R, Belov, P, Magnano, C, Krawiecki, J, Hagemeier, J, Bergsland, N, Beggs, CB, and Zivadinov, R
- Abstract
Objectives To assess the relationship between cross-sectional area of internal jugular veins and brain volumes in healthy individuals without neurologic disease. Methods A total of 193 healthy individuals without neurologic disease (63 male and 130 female; age > 20 to < 70 years) received magnetic resonance venography and structural brain magnetic resonance imaging at 3T. The internal jugular vein cross-sectional area was assessed at C2–C3, C4, C5–C6, and C7–T1. Normalized whole brain volume was assessed. Partial correlation analyses were used to determine associations. Results There was an inverse relationship between normalized whole brain volume and total internal jugular vein cross-sectional area (C7–T1: males r = −0.346, p = 0.029; females r = −0.301, p = 0.002). After age adjustment, association of normalized whole brain volume and normalized gray matter volume with internal jugular vein cross-sectional area became positive in males (normalized whole brain volume and right internal jugular vein cross-sectional area (C2–C3) changed from r = −0.163 to r = 0.384, p = 0.002), but not in the females. Conclusion Sex differences exist in the relationship between brain volume and internal jugular vein cross-sectional area in healthy individuals without neurologic disease.
- Published
- 2016
8. Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow
- Author
-
Beggs, CB, Magnano, C, Shepherd, SJ, Marr, K, Valnarov, V, Hojnacki, D, Bergsland, N, Belov, P, Grisafi, S, Dwyer, MG, Carl, E, Weinstock-Guttman, B, and Zivadinov, R
- Abstract
To investigate cerebrospinal fluid (CSF) dynamics in the aqueduct of Sylvius (AoS) in chronic cerebrospinal venous insufficiency (CCSVI)-positive and -negative healthy individuals using cine phase contrast imaging.Fifty-one healthy individuals (32 CCSVI-negative and 19 age-matched CCSVI-positive subjects) were examined using Doppler sonography (DS). Diagnosis of CCSVI was established if subjects fulfilled ≥2 venous hemodynamic criteria on DS. CSF flow and velocity measures were quantified using a semiautomated method and compared with clinical and routine 3T MRI outcomes.CCSVI was associated with increased CSF pulsatility in the AoS. Net positive CSF flow was 32% greater in the CCSVI-positive group compared with the CCSVI-negative group (P = 0.008). This was accompanied by a 28% increase in the mean aqueductal characteristic signal (ie, the AoS cross-sectional area over the cardiac cycle) in the CCSVI-positive group compared with the CCSVI-negative group (P = 0.021).CSF dynamics are altered in CCSVI-positive healthy individuals, as demonstrated by increased pulsatility. This is accompanied by enlargement of the AoS, suggesting that structural changes may be occurring in the brain parenchyma of CCSVI-positive healthy individuals.
- Published
- 2014
9. Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study
- Author
-
GALIA, Massimo, MIDIRI, Massimo, BARTOLOTTA, Tommaso Vincenzo, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A, Multicenter Trial Group of the Society for the Study of Thalassemia, Haemoglobinopathies, Galia M, Midiri M, Bartolotta V, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A, and Multicenter Trial Group of the Society for the Study of Thalassemia and Haemoglobinopathies
- Subjects
thalassemia major ,myocardial iron content - Abstract
The purpose of this study was to evaluate if the variations of heart magnetic resonance imaging in beta-thalassemia major patients treated with Deferoxamine B mesylate (DF) or Deferiprone (L1) chelation therapy is a useful tool of the indirect myocardial iron content determination. For this reason, a prospective study was carried out. Seventy-two consecutive patients with beta-thalassemia major (35 treated with DF and 37 with L1) were studied. The main outcome results were laboratory parameters including determination of the liver iron concentration (LIC) and magnetic resonance imaging (MRI) of the heart and liver. The heart to muscle signal intensity ratios (HSIRs) were significantly increased in both the DF (t = -2.8; p < 0.01) and L1 (t = -3.1; p < 0.01) groups after one year of treatment No statistically significant difference in the values of HSIRs was present between the two groups at the beginning of treatment (p = 0.25; t = 1.13), and after one year of treatment (p = 0.20; t = 1.28). The HSIR were inversely correlated to the LIC (r = -0.52; p < 0.001) but not with ferritin levels (r = 0.10; p = 0.18). A positive correlation was found between the variation of HSIRs and that of the liver signal intensity ratios (r=0.52; p < 0.001), and a mild correlation (r = 0.40; p < 0.001) was found between the gamma glutamyltransferase (gammaGt) levels and the HSIRs values. Our data confirm that heart MRI is sensitive enough to detect significant variations of the mean HSIR during iron chelation with DF or L1.
- Published
- 2003
10. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls
- Author
-
Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, Weinstock-Guttman B, Claudiu Schirda, Magnano C, Am, Malagoni, Kennedy C, Bartolomei I, Salvi F, Zivadinov R, Radiology and nuclear medicine, and NCA - Multiple Sclerosis and Other Neuroinflammatory Diseases
- Subjects
Adult ,Male ,Pilot Projects ,Ultrasonography, Doppler ,Phlebography ,Middle Aged ,Sensitivity and Specificity ,Cross-Sectional Studies ,Multiple Sclerosis, Relapsing-Remitting ,Spinal Cord ,Venous Insufficiency ,Predictive Value of Tests ,Regional Blood Flow ,Humans ,Female ,Jugular Veins ,Magnetic Resonance Angiography - Abstract
Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of primary veins outside the skull that restrict normal outflow of blood from the brain. CCSVI was recently described as highly prevalent in patients with multiple sclerosis (MS), and can be non-invasively diagnosed by Doppler sonography (DS) and invasively by selective venography (SV). The aim of this paper was to investigate the value of neck magnetic resonance venography (MRV) for the diagnosis of CCSVI compared to DS and SV in patients with MS and in healthy controls (HC).Ten MS patients and 7 HC underwent DS, 2D-Time-Of-Flight venography (TOF) and 3D-Time Resolved Imaging of Contrast Kinetics angiography (TRICKS). MS patients also underwent SV. The internal jugular veins (IJVs) and the vertebral veins (VVs) were assessed by both MRV sequences, and the findings were validated against SV and DS. SV has been considered the diagnostic gold standard for MS patients.All MS patients and none of the HC presented CCSVI, according to the DS criteria. This was confirmed by SV. For CCSVI diagnosis, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, whereas the figures were 40%, 85%, 58%, 80% and 50% for 3D-TRICKS, and 30%, 85%, 52%, 75% and 46% for 2D-TOF in the IJVs. In MS patients, compared to SV, DS showed sensitivity, specificity, accuracy, PPV and NPV of 100%, 75%, 95%, 94% and 100%, whereas the figures were 31%, 100%, 45%, 100% and 26% for 3D-TRICKS and 25%, 100%, 40%, 100% and 25% for 2D-TOF in the IJVs.The use of MRV for diagnosis of CCSVI in MS patients has limited value, and the findings should be interpreted with caution and confirmed by other imaging techniques such as DS and SV.
- Published
- 2010
11. Scientific network for the study of the alpha-thalassemia and Hb variants in Southern Italy: a)Molecular, biochemical and epidemiologic studies; b) Advanced biotechnologies for mutation detection; c) Genotype and phenotype database
- Author
-
Lacerra G, Musollino G, Scarano C, Lagona L, Caruso D, Testa R, Medulla E, Friscia MG, La Porta G, Nota L, Gaudiano C, Caldora M, Colella R, Di Girgenti C, Magnano C, Ciaccio C, Romeo MA, Di Noce F, Prezioso R, and Carestia C.
- Published
- 2007
12. Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial
- Author
-
Maggio, A, Capra, M, Cuccia, L, Gagliardotto, F, Magnano, C, Caruso, V, Gerardi, C, M G, Friscia, Argento, C, Campisi, S, Cantella, F, Cianciulli, P, Commendatore, F, D G, D’Ascola, Fidone, C, Filosa, A, Fragasso, A, Galati, M, Giuffrida, G, Giugno, R, Lombardo, T, Malizia, R, Meo, A, Rizzo, M, Roccamo, G, M A, Romeo, Violi, P, Pepe, A, D’Amico, G, and Morabito, A
- Published
- 2007
13. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
- Author
-
Cappellini, MD Cohen, A Piga, A Bejaoui, M Perrone, S and Agaoglu, L Aydinok, Y Kattamis, A Kilinc, Y Porter, J Capra, M Galanello, R Fattoum, S Drelichman, G and Magnano, C Verissimo, M Athanassiou-Metaxa, M Giardina, P and Kourakli-Symeonidis, A Janka-Schaub, G Coates, T and Vermylen, C Olivieri, N Thuret, I Opitz, H and Ressayre-Djaffer, C Marks, P Alberti, D
- Abstract
Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to demonstrate the efficacy of deferasirox in regularly transfused patients with beta-thalassemia aged 2 years or older. Patients were randomized and received treatment with deferasirox (n = 296) or deferoxamine (n = 290), with dosing of each according to baseline liver iron concentration (LIC). The primary endpoint was maintenance or reduction of LIC; secondary endpoints included safety and tolerability, change in serum ferritin level, and net body iron balance. In both arms, patients with LIC values of 7 mg Fe/g dry weight (dw) or higher had significant and similar dose-dependent reductions in LIC and serum ferritin, and effects on net body iron balance. However, the primary endpoint was not met in the overall population, possibly due to the fact that proportionally lower doses of deferasirox relative to deferoxamine were administered to patients with LIC values less than 7 mg Fe/g dw. The most common adverse events included rash, gastrointestinal disturbances, and mild nonprogressive increases in serum creatinine. No agranulocytosis, arthropathy, or growth failure was associated with deferasirox administration. Deferasirox is a promising once-daily oral therapy for the treatment of transfusional iron overload.
- Published
- 2006
14. Nuove mutazioni delta-talassemiche in famiglie dell'Italia meridionale
- Author
-
Lacerra G, Musollino G, Scarano C, Lagona L, Caruso D, Testa R, Friscia MG, Medulla E, Nota L, Gaudiano C, Mastrullo L, Caldora M, Romeo MA, Ciaccio C, Magnano C, and Carestia C.
- Abstract
L'identificazione delle mutazioni del gene delta-globinico è importante sia per la prevenzione della beta thalassemia omozigote sia per la conoscenza della variabilità genetica in studi popolazionistici. Centoquarantasei famiglie sono state selezionate mediante dosaggio dell'HB A2 TAG) o per l'alterazione del consenso del sito di poliadenilazione (AATAAA>AATTAA). Negli altri 3 casi la mutazione porta ad una sostituzione aminocidica; tuttavia in nessun caso la nuova variante attesa è presente sul cromatogramma HPLC. Il confronto con il fenotipo delle mutazioni beta-globiniche suggerisce che nel caso delle mutazioni Hb A2-Catania ed Hb A2-Scarano l'assenza dell'Hb A2 variante potrebbe essere dovuta ad una comigrazione con la normale HbA; infatti, la variante beta con la stessa sostituzione da origine ad una "fast-mooving-band". Pertanto, i valori bassi di Hb A2 nei rispettivi portatori potrebbero essere dovuti soltanto a problemi tecnici di detection dell'Hb A2 variante. Nel caso della mutazione Hb A2-Foggia, invece, l'assenza della variante dovrebbe essere dovuta alla sua instabilità considerato che la variante beta corrispondente è associata ad un fenotipo di anemia emolitica (corpi di Heinz e riduzione della percentuale di variante circolante al 24%).
- Published
- 2006
15. Epidemiologia molecolare dell'alfa talassemia nell'Italia Meridionale: correlazione genotipo-fenotipo in 525 portatori del genotipo alphaalpha/-alpha3.7
- Author
-
Lacerra G, Di Noce F, Musollino G, Prezioso R, Gaudiano C, Masciandaro S, Friscia MG, Ciaccio C, Caruso D, Testa R, Romeo MA, Lagona L, Medulla E, Magnano C, Virruso L, Di Girgenti C, Capra M, Maggio A, Nota L, Scarano C, La Porta G, Bisconte MG, and Carestia C.
- Published
- 2004
16. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases
- Author
-
Prati, D, Maggioni, M, Milani, S, Cerino, M, Cianciulli, P, Coggi, G, Forni, Gl, Magnano, C, Meo, Anna, Gramignoli, R, Rebulla, P, Fiorelli, G, and Cappellini, Md
- Published
- 2004
17. Hb G-San Jose variant levels correlate with alpha-thalassemia genotypes
- Author
-
Lacerra G., Fiorito M., Pagano L., Testa R., Magnano C., Medulla E., and Carestia C..
- Abstract
Hb G-San Jose or beta7(A4)Glu-->Gly has been reported in Southern Italian or Mexican families. We have studied four families from Sicily and Campania, Southern Italy. In six carriers, the hemoglobin variant level ranged from 32 to 38%. In four double heterozygotes for Hb G-San Jose and alpha-thalassemia the variant level showed a strong correlation with the alpha-thalassemia genotype. In fact, the variant level was 15% when interacting with the - (alpha)20.5/alphaalpha, 19.6% with the alphaalpha/alphaPoly Aalpha, and 24.8% with alphaalpha/alpha(-5) ntalpha genotypes. In two double heterozygotes for Hb G-San Jose and beta+ -IVS-I-6 (T-->C) the hemoglobin variant level was 67%. These data show that the reduced synthesis of alpha chains causes drastic reduction of probability to form Hb G-San Jose in favor of the formation of Hb A. Moreover, this reduction, (i) correlates with the type of alpha-thalassemia genotype and with the degree of the alpha chain deficiency, and (ii) is, most probably, more marked than the degree of alpha chain reduction. The minor affinity of the beta chain variant for the alpha chains associated with the reduced synthesis of the alpha chains is probably the principal cause of the variant hemoglobin reduction. Moreover, the rapid removal of the abnormal chains by proteolytic enzymes must have an essential role in order to reduce the chain variant pool. These conclusions are in agreement with the results obtained in reticulocyte and in vitro recombination experiments.
- Published
- 2002
18. SQUID biosusceptometry in hematological diseases
- Author
-
Janka, Ge, Agus, A, Batzella, Mg, Capra, M, DE MATTIA, D, DE SANCTIS, V, DI GREGORIO, F, Duerken, M, Fischer, R, Forni, Gl, Fortini, M, Galanello, R, Graubner, Ub, Janssen, G, Kattamis, A, Lombardo, T, Longo, F, Magnano, C, Meo, Anna, Nielsen, P, Niemeyer, C, Piga, A, Politis, C, and Toendury, P.
- Published
- 2001
19. Hypothesis on the origin and spreaading of the Hb G-San Josè in Campania, Calabria and Eastern Sicily
- Author
-
Lacerra G, De Angioletti M, Pagano L, Magnano C, Medulla E, and Carestia C.
- Published
- 2001
20. Raccomandazioni per l’intervento psico-sociale nella talassemia
- Author
-
Masera, G, Monguzzi, W, Piga, A, Massaglia, M. P., Vania, Andrea, DE PASCALE, Adele, Magnano, C, and DI PALMA, A.
- Subjects
"intervento psicologico" ,talassemia - Published
- 1996
21. Subcortical Deep Gray Matter SWI-Filtered Phase and Atrophy Are Associated with Disability in MS (S21.005)
- Author
-
Zivadinov, R., primary, Hagemeier, J., additional, Heininen-Brown, M., additional, Poloni, G., additional, Bergsland, N., additional, Schirda, C., additional, Magnano, C., additional, Kennedy, C., additional, Carl, E., additional, Dwyer, M., additional, and Weinstock-Guttman, B., additional
- Published
- 2012
- Full Text
- View/download PDF
22. Iron Deposition on SWI Filtered Phase in the Subcortical Deep Gray Matter of Clinically Isolated Syndrome Patients May Precede Structure-Specific Atrophy (P03.032)
- Author
-
Hagemeier, J., primary, Weinstock-Guttman, B., additional, Bergsland, N., additional, Heininen-Brown, M., additional, Carl, E., additional, Kennedy, C., additional, Magnano, C., additional, Hojnacki, D., additional, Dwyer, M., additional, and Zivadinov, R., additional
- Published
- 2012
- Full Text
- View/download PDF
23. Iron Deposition in Multiple Sclerosis Lesions Measured by Susceptibility-Weighted Imaging Filtered Phase. A Case Control Study (P03.042)
- Author
-
Dwyer, M., primary, Heininen-Brown, M., additional, Hagemeier, J., additional, Poloni, G., additional, Bergsland, N., additional, Magnano, C., additional, Durfee, J., additional, Kennedy, C., additional, Carl, E., additional, Weinstock-Guttman, B., additional, and Zivadinov, R., additional
- Published
- 2012
- Full Text
- View/download PDF
24. Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy
- Author
-
Hagemeier, J., primary, Weinstock-Guttman, B., additional, Bergsland, N., additional, Heininen-Brown, M., additional, Carl, E., additional, Kennedy, C., additional, Magnano, C., additional, Hojnacki, D., additional, Dwyer, M.G., additional, and Zivadinov, R., additional
- Published
- 2012
- Full Text
- View/download PDF
25. Assessing Abnormal Iron Content in the Deep Gray Matter of Patients with Multiple Sclerosis versus Healthy Controls
- Author
-
Habib, C.A., primary, Liu, M., additional, Bawany, N., additional, Garbern, J., additional, Krumbein, I., additional, Mentzel, H.-J., additional, Reichenbach, J., additional, Magnano, C., additional, Zivadinov, R., additional, and Haacke, E.M., additional
- Published
- 2011
- Full Text
- View/download PDF
26. Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: A Pilot Longitudinal Study
- Author
-
Zivadinov, R., primary, Galeotti, R., additional, Hojnacki, D., additional, Menegatti, E., additional, Dwyer, M.G., additional, Schirda, C., additional, Malagoni, A.M, additional, Marr, K., additional, Kennedy, C., additional, Bartolomei, I., additional, Magnano, C., additional, Salvi, F., additional, Weinstock-Guttman, B., additional, and Zamboni, P., additional
- Published
- 2011
- Full Text
- View/download PDF
27. Role of epoetins in beta-thalassemia minor patients with solid tumors undergoing chemotherapy: Results of a retrospective analysis
- Author
-
Soto Parra, H. J., primary, Medula, E., additional, Latteri, F., additional, Lavenia, G., additional, Amadio, P., additional, Cordio, S., additional, and Magnano, C., additional
- Published
- 2007
- Full Text
- View/download PDF
28. Thrombophilia in thalassemia major patients: Analysis of genetic predisposing factors
- Author
-
Iolascon, A., Giordano, P., Storelli, S., Li, H. -H, Coppola, B., Piga, A., Fantola, E., Forni, G., Cianciulli, P., Silverio Perrotta, Magnano, C., Maggio, A., Mangiagli, A., Devoto, M., Iolascon, Achille, Giordano, P, Storelli, S, Li, Hh, Coppola, B, Piga, A, Fantola, E, Forni, G, Cianciulli, P, Perrotta, S, Magnano, C, Maggio, A, Mangiagli, A, Devoto, M., Iolascon, A, and Perrotta, Silverio
- Subjects
Adult ,Male ,Adolescent ,DNA Mutational Analysis ,Middle Aged ,Risk Factors ,hemic and lymphatic diseases ,Humans ,Thalassemia ,Thrombophilia ,Female ,Genetic Predisposition to Disease ,Child ,Retrospective Studies - Abstract
Thromboembolic phenomenona have been described in patients with thalassemia major. In a multicenter, retrospective study we investigated the effect of factor V (FV Leiden), prothrombin (FII), methylene-tetrahydrofolate reductase (MTHFR), PlA2 glycoprotein IIIa (GpIIIa) and factor VII gene polymorphisms on the risk of thrombosis in thalassemic patients. A higher prevalence of the FVII H7 allele in subjects without thrombosis suggests that this genetic marker confers protection against thrombosis.
29. The incidence and natural course of transfusion-associated GB virus C/hepatitis G virus infection in a cohort of thalassemic patients. The Cooleycare Cooperative Group
- Author
-
Daniele Prati, Zanella A, Bosoni P, Rebulla P, Farma E, De Mattei C, Capelli C, Mozzi F, Gallisai D, Magnano C, Melevendi C, and Sirchia G
- Subjects
Adult ,Male ,Adolescent ,Hepatitis, Viral, Human ,Flaviviridae ,beta-Thalassemia ,Infant, Newborn ,Infant ,Transfusion Reaction ,RNA-Directed DNA Polymerase ,Polymerase Chain Reaction ,Immunoenzyme Techniques ,Risk Factors ,Child, Preschool ,Humans ,RNA, Viral ,Female ,Longitudinal Studies ,Prospective Studies ,Child - Abstract
To evaluate the risk of transmitting blood-borne GB virus C/hepatitis G virus (GBV-C/HGV) and to define the natural course of infection, we performed a prospective study in a cohort of multitransfused beta-thalassemics during a 6-year follow-up period. We analyzed serum samples of 150 patients collected at 3-year intervals from 1990 to 1996. GBV-C/HGV RNA was determined by reverse transcriptase-polymerase chain reaction and antibodies to E2-protein by an enzyme immunoassay. At baseline, 14.5% of patients had viremia and 18.5% anti-E2. None of the patients with anti-E2 in 1990 subsequently became viremic. Of the 100 GBV-C/HGV RNA-, anti-E2- patients, 10 acquired infection during follow-up, as indicated by positivity of GBV-C/HGV RNA (n = 2), anti-E2 (n = 7), or both markers (n = 1) in 1996. The incidence was 1.7 per 100 person-years (95% confidence interval [CI], 0.8 to 3). Since approximately 19,000 blood units were transfused to these patients during follow-up, the risk of infection was 5.3 in 10,000 units (95% CI, 2 to 8.5). Six of 22 viremic patients cleared the virus during follow-up; 4 of them became anti-E2+. Twelve of 28 patients lost anti-E2 reactivity during follow-up. In conclusion, more than 25% of infections resolve within 6 years; the presence of anti-E2 seems to be protective against infection. Anti-E2 reactivity may decrease with time.
30. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases
- Author
-
Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, Gl, Forni, Magnano C, Meo A, roberto gramignoli, Rebulla P, Fiorelli G, Md, Cappellini, and Cooleycare Cooperative Group
31. Clinical and histological characterization of liver disease in patients with transfusion-dependent β-thalassemia. A multicenter study of 117 cases
- Author
-
Prati, D., Marco Maggioni, Milani, S., Cerino, M., Cianciulli, P., Coggi, G., Forni, G. L., Magnano, C., Meo, A., Gramignoli, R., Rebulla, P., Fiorelli, G., and Cappellini, M. D.
32. Origin and spread of HbG-San Josè in Southern Italy
- Author
-
Giuseppina Lacerra, Angioletti, M., Pagano, L., Magnano, C., Medulla, E., and Carestia, C.
33. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: A pilot case-control study
- Author
-
Zivadinov R, Schirda C, Mg, Dwyer, Me, Haacke, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Am, Malagoni, Ds, Wack, Hojnacki D, Kennedy C, Carl E, Niels Bergsland, Hussein S, Poloni G, Bartolomei I, Salvi F, and Zamboni P
- Subjects
Adult ,Male ,Iron ,New York ,Brain ,Pilot Projects ,Constriction, Pathologic ,Magnetic Resonance Imaging ,Severity of Illness Index ,Disability Evaluation ,Multiple Sclerosis, Relapsing-Remitting ,Italy ,Spinal Cord ,Venous Insufficiency ,Predictive Value of Tests ,Regional Blood Flow ,Case-Control Studies ,Cerebrovascular Circulation ,Chronic Disease ,Humans ,Female ,Atrophy ,Jugular Veins - Abstract
Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular phenomenon recently described in multiple sclerosis (MS) that is characterized by stenoses affecting the main extracranial venous outflow pathways and by a high rate of cerebral venous reflux that may lead to increased iron deposition in the brain. Aim of this study was to investigate the relationship between CCSVI and iron deposition in the brain of MS patients by correlating venous hemodynamic (VH) parameters and iron concentration in deep-gray matter structures and lesions, as measured by susceptibility-weighted imaging (SWI), and to preliminarily define the relationship between iron measures and clinical and other magnetic resonance imaging (MRI) outcomes.Sixteen (16) consecutive relapsing-remitting MS patients and 8 age- and sex-matched healthy controls (HC) were scanned on a GE 3T scanner, using SWI.All 16 MS patients fulfilled the diagnosis of CCSVI (median VH=4), compared to none of the HC. In MS patients, the higher iron concentration in the pulvinar nucleus of the thalamus, thalamus, globus pallidus, and hippocampus was related to a higher number of VH criteria (P0.05). There was also a significant association between a higher number of VH criteria and higher iron concentration of overlapping T2 (r=-0.64, P=0.007) and T1 (r=-0.56, P=0.023) phase lesions. Iron concentration measures were related to longer disease duration and increased disability as measured by EDSS and MSFC, and to increased MRI lesion burden and decreased brain volume.The findings from this pilot study suggest that CCSVI may be an important mechanism related to iron deposition in the brain parenchyma of MS patients. In turn, iron deposition, as measured by SWI, is a modest-to-strong predictor of disability progression, lesion volume accumulation and atrophy development in patients with MS.
34. Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease
- Author
-
Belov P, Magnano C, Krawiecki J, Hagemeier J, Niels Bergsland, Beggs C, and Zivadinov R
- Subjects
cardiovascular system - Abstract
Objectives To assess the relationship between cross-sectional area of internal jugular veins and brain volumes in healthy individuals without neurologic disease. Methods A total of 193 healthy individuals without neurologic disease (63 male and 130 female; age > 20 to
35. Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients
- Author
-
Pietro Violi, R. Malizia, Domenico Giuseppe D'Ascola, Alessia Pepe, Alberto Morabito, Saveria Campisi, Gaetano Restivo Pantalone, Maria Antonietta Romeo, Calogera Gerardi, Michele Rizzo, Alessandra Quota, Christian Gluud, Aurelio Maggio, Paolo Cianciulli, Gennaro D'Amico, Francesco Gagliardotto, Aldo Filosa, Carmelo Magnano, Crocetta Argento, Paolo Rigano, Luciano Prossomariti, Vincenzo Caruso, Carmelo Fidone, Angela Vitrano, Liana Cuccia, Marcello Capra, Pantalone, GR, Maggio, A, Vitrano, A, Capra, M, Cuccia, L, Gagliardotto, F, Filosa, A, Romeo, MA, Magnano, C, Caruso, V, Argento, C, Gerardi, C, Campisi, S, Violi, P, Malizia, R, Cianciulli, P, Rizzo, M, D'Ascola, DG, Quota, A, Prossomariti, L, Fidone, C, Rigano, P, Pepe, A, D'Amico, G, Morabito, A, and Gluud, C
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Pyridones ,Thalassemia ,Clinical Biochemistry ,Deferoxamine ,Iron Chelating Agents ,Gastroenterology ,Drug Administration Schedule ,law.invention ,chemistry.chemical_compound ,Young Adult ,Randomized controlled trial ,law ,Internal medicine ,Medicine ,Humans ,Deferiprone ,Adverse effect ,Genetics (clinical) ,Survival analysis ,business.industry ,Biochemistry (medical) ,Serum ferritin level ,beta-Thalassemia ,Hematology ,Iron chelation therapy ,medicine.disease ,Chelation Therapy ,Treatment Outcome ,chemistry ,Drug Therapy, Combination ,Female ,business ,Thalassemia, Iron overload, Iron chelation therapy, Deferiprone (L1), Deferroxamine (DFO) ,medicine.drug ,Follow-Up Studies - Abstract
In β-thalassemia major (β-TM) patients, iron chelation therapy is mandatory to reduce iron overload secondary to transfusions. Recommended first line treatment is deferoxamine (DFO) from the age of 2 and second line treatment after the age of 6 is deferiprone (L1). A multicenter randomized open-label trial was designed to assess the effectiveness of long-term alternating sequential L1-DFO versus L1 alone iron chelation therapy in β-TM patients. Deferiprone 75 mg/kg 4 days/week and DFO 50 mg/kg/day for 3 days/week was compared with L1 alone 75 mg/kg 7 days/week during 5-year follow-up. A total of 213 thalassemia patients were randomized and underwent intention-to-treat analysis. Statistically, a decrease of serum ferritin levels was significantly higher in alternating sequential L1-DFO patients compared with L1 alone patients (p = 0.005). Kaplan-Meier survival analysis for the two chelation treatments did not show statistically significant differences (log-rank test, p = 0.3145). Adverse events and costs were comparable between the groups. Alternating sequential L1-DFO treatment decreased serum ferritin concentration during a 5-year treatment by comparison to L1 alone, without significant differences of survival, adverse events or costs. These findings were confirmed in a further 21-month follow-up. These data suggest that alternating sequential L1-DFO treatment may be useful for some β-TM patients who may not be able to receive other forms of chelation treatment.
- Published
- 2011
36. Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassemia major patients: a randomised clinical trial
- Author
-
Paolo Rigano, Luciano Prossomariti, Domenico Giuseppe D'Ascola, Michele Rizzo, Christian Gluud, Aldo Filosa, Vincenzo Caruso, Calogera Gerardi, Carmelo Magnano, Pietro Violi, Saveria Campisi, Alessia Pepe, Gennaro D'Amico, Paolo Cianciulli, Carmelo Fidone, Alberto Morabito, Marcello Capra, Aurelio Maggio, Angela Vitrano, Francesco Gagliardotto, Alessandra Quota, Liana Cuccia, R. Malizia, Maria Antonietta Romeo, Crocetta Argento, Maggio, A, Vitrano, A, Capra, M, Cuccia, L, Gagliardotto, F, Filosa, A, Romeo, MA, Magnano, C, Caruso, V, Argento, C, Gerardi, C, Campisi, S, Violi, P, Malizia, R, Cianciulli, P, Rizzo, M, D’Ascola, DG, Quota, A, Prossomariti, L, Fidone, C, Rigano, P, Pepe, A, D’Amico, G, Morabito, A, and Gluud, C
- Subjects
Adult ,Male ,medicine.medical_specialty ,Randomization ,Adolescent ,Pyridones ,Administration, Oral ,Kaplan-Meier Estimate ,Deferoxamine ,Infusions, Subcutaneous ,Iron Chelating Agents ,Gastroenterology ,law.invention ,Young Adult ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Deferiprone ,Adverse effect ,Decreased serum ferritin ,Survival analysis ,business.industry ,Hematology ,Surgery ,Clinical trial ,Chelation, thalassaemia, clinical trials, red blood cell disorders, iron overload ,Treatment Outcome ,chemistry ,Ferritins ,Thalassemia ,Drug Therapy, Combination ,Female ,business ,Follow-Up Studies ,medicine.drug - Abstract
A multicentre randomized open-label trial was designed to assess the effectiveness of long-term sequential deferiprone–deferoxamine (DFO–DFP) versus DFP alone to treat thalassaemia major (TM). DFP at 75 mg/kg, divided into three oral daily doses, for 4 d/week and DFO by subcutaneous infusion (8–12 h) at 50 mg/kg per day for the remaining 3 d/week was compared with DFP alone at 75 mg/kg, administered 7 d/week during a 5-year follow-up. The main outcome measures were differences between multiple observations of serum ferritin concentrations. Secondary outcomes were survival analysis, adverse events, and costs. Consecutive thalassaemia patients (275) were assessed for eligibility; 213 of these were randomized and underwent intention-to-treat analysis. The decrease of serum ferritin levels during the treatment period was statistically significant higher in sequential DFP–DFO patients compared with DFP-alone patients (P = 0.005). Kaplan– Meier survival analysis for the two chelation treatments did not show any statistically significant differences (log-rank test, P = 0.3145). Adverse events and costs were comparable between the groups. The trial results show that sequential DFP–DFO treatment compared with DFP alone significantly decreased serum ferritin concentration during treatment for 5 years without significant differences regarding survival, adverse events, or costs.
- Published
- 2009
37. Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
- Author
-
Michele Rizzo, Crocetta Argento, Angela Vitrano, Pietro Violi, R. Malizia, Domenico Giuseppe D'Ascola, Carmelo Magnano, Aurelio Maggio, Marcello Capra, Saveria Campisi, Francesco Cantella, Francesca Valeria Commendatore, Francesco Gagliardotto, Liana Cuccia, Giovanni Giugno, Rocca Cingari, Carmelo Fidone, Maria Antonietta Romeo, Paolo Rigano, Luciano Prossomariti, Anna Meo, Paolo Cianciulli, Gaetano Roccamo, Aldo Filosa, Maria Concetta Galati, Gaetano Giuffrida, Vincenzo Caruso, Turi Lombardo, Angela Ciancio, Calogera Gerardi, Maggio, A, Vitrano, A, Capra, M, Cuccia, L, Gagliardotto, F, Filosa, A, Magnano, C, Rizzo, M, Caruso, V, Gerardi, C, Argento, C, Campisi, S, Cantella, F, Commendadore, F, D’Ascola, DG, Fidone, C, Ciancio, A, Galati, MC, Giuffrida, G, Cingari, R, Giugno, G, Lombardo, T, Prossomariti, L, Malizia, R, Meo, A, Roccamo, G, Romeo, MA, Violi, P, Cianciulli, P, and Rigano, P
- Subjects
Male ,Thalassemia ,Kaplan-Meier Estimate ,law.invention ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Cause of Death ,Neoplasms ,Deferiprone ,Prospective Studies ,Child ,Cause of death ,Hazard ratio ,Hematology ,Middle Aged ,Combined Modality Therapy ,Survival Rate ,Thalassemia, survival, chelation, treatment, trial, thalassemia major ,Combination ,Splenectomy ,Molecular Medicine ,Drug Therapy, Combination ,Female ,Adult ,medicine.medical_specialty ,Adolescent ,Pyridones ,Deferoxamine ,Iron Chelating Agents ,Young Adult ,Drug Therapy ,Internal medicine ,medicine ,Humans ,Blood Transfusion ,Chelation Therapy ,Heart Failure ,Kaplan-Meiers Estimate ,Proportional Hazards Models ,beta-Thalassemia ,Molecular Biology ,Survival rate ,Survival analysis ,business.industry ,Proportional hazards model ,Cell Biology ,medicine.disease ,Surgery ,chemistry ,business - Abstract
The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop progressive accumulation of iron. This can lead to tissue damage and eventually death, particularly from cardiac disease. Previous studies that investigated iron chelation treatments, including retrospective and prospective non-randomised clinical trials, suggested that mortality, due mainly to cardiac damage, was reduced or completely absent in patients treated with deferiprone (DFP) alone or a combined deferiprone-deferoxamine (DFP-DFO) chelation treatment. However, no survival analysis has been reported for a long-term randomised control trial. Here, we performed a multicenter, long-term, randomised control trial that compared deferoxamine (DFO) versus DFP alone, sequential DFP-DFO, or combined DFP-DFO iron chelation treatments. The trial included 265 patients with thalassemia major, with 128 (48.3%) females and 137 (51.7%) males. No deaths occurred with the DFP-alone or the combined DFP-DFO treatments. One death occurred due to graft versus host disease (GVHD) in a patient that had undergone bone marrow transplantation; this patient was censored at the time of transplant. Only one death occurred with the DFP-DFO sequential treatment in a patient that had experienced an episode of heart failure one year earlier. Ten deaths occurred with the deferoxamine treatment. The main factors that correlated with an increase in the hazard ratio for death were: cirrhosis, arrhythmia, previous episode of heart failure, diabetes, hypogonadism, and hypothyroidism. In a Cox regression model, the interaction effect of sex and age was statistically significant (p-value
- Published
- 2009
38. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
- Author
-
Christiane Vermylen, Thomas D. Coates, Yesim Aydinok, Gritta Janka-Schaub, Herbert Opitz, Yurdanur Kilinç, Renzo Galanello, Leyla Agaoglu, Alexandra Kourakli-Symeonidis, Silverio Perrotta, Miranda Athanassiou-Metaxa, Marcello Capra, C. Ressayre-Djaffer, Carmelo Magnano, Isabelle Thuret, Patricia J. Giardina, Mônica Pinheiro de Almeida Veríssimo, Nancy F. Olivieri, Guillermo Drelichman, John B. Porter, Mohamed Bejaoui, Antonis Kattamis, Maria Domenica Cappellini, Alan R. Cohen, Slaheddine Fattoum, Antonio Piga, Daniele Alberti, Peter W. Marks, Çukurova Üniversitesi, Cappellini, M., Cohen, A., Piga, A., Bejaoui, M., Perrotta, Silverio, Agaoglu, L., Aydinok, Y., Kattamis, A., Kilinc, Y., Porter, J., Capra, M., Galanello, R., Fattoum, S., Drelichman, G., Magnano, C., Verissimo, M., ATHANASSIOU METAXA, M., Giardina, P., KOURAKLI SYMEONIDIS, A., JANKA SCHAUB, G., Coates, T., Vermylen, C., Ollivieri, N., Thuret, I., Opitz, H., RESSAYRE DJAFFER, C., Marks, P., Alberti, D., and Ege Üniversitesi
- Subjects
Adult ,Male ,thalassemia ,medicine.medical_specialty ,Liver Iron Concentration ,Pediatrics ,Adolescent ,Iron ,Immunology ,Population ,Administration, Oral ,Deferoxamine ,Iron Chelating Agents ,Benzoates ,Biochemistry ,Gastroenterology ,Drug Administration Schedule ,cooley ,chemistry.chemical_compound ,Oral administration ,Internal medicine ,medicine ,Humans ,Child ,education ,education.field_of_study ,iron chelator ,business.industry ,ferritin ,beta-Thalassemia ,Deferasirox ,Beta thalassemia ,Cell Biology ,Hematology ,Middle Aged ,Triazoles ,medicine.disease ,Liver ,chemistry ,Tolerability ,Child, Preschool ,Female ,Safety ,Deferiprone ,business ,medicine.drug - Abstract
WOS: 000237217600020, PubMed ID: 16352812, Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3 trial was conducted to demonstrate the efficacy of deferasirox in regularly transfused patients with beta-thalassemia aged 2 years or older. Patients were randomized and received treatment with deferasirox (n = 296) or deferoxamine (n = 290), with dosing of each according to baseline liver iron concentration (LIC). The primary endpoint was maintenance or reduction of LIC; secondary endpoints included safety and tolerability, change in serum ferritin level, and net body iron balance. In both arms, patients with LIC values of 7 mg Fe/g dry weight (dw) or higher had significant and similar dose-dependent reductions in LIC and serum ferritin, and effects on net body iron balance. However, the primary endpoint was not met in the overall population, possibly due to the fact that proportionally lower doses of deferasirox relative to deferoxamine were administered to patients with LIC values less than 7 mg Fe/g dw. The most common adverse events included rash, gastrointestinal disturbances, and mild nonprogressive increases in serum creatinine. No agranulocytosis, arthropathy, or growth failure was associated with deferasirox administration. Deferasirox is a promising once-daily oral therapy for the treatment of transfusional iron overload.
- Published
- 2006
39. HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B.
- Author
-
Bruce JW, Park E, Magnano C, Horswill M, Richards A, Potts G, Hebert A, Islam N, Coon JJ, Gitter A, Sherer N, and Ahlquist P
- Subjects
- Humans, Aurora Kinase B metabolism, Proteomics, CD4-Positive T-Lymphocytes metabolism, CD4 Antigens metabolism, HIV-1 physiology, HIV Infections metabolism
- Abstract
HIV-1 spreads efficiently through direct cell-to-cell transmission at virological synapses (VSs) formed by interactions between HIV-1 envelope proteins (Env) on the surface of infected cells and CD4 receptors on uninfected target cells. Env-CD4 interactions bring the infected and uninfected cellular membranes into close proximity and induce transport of viral and cellular factors to the VS for efficient virion assembly and HIV-1 transmission. Using novel, cell-specific stable isotope labeling and quantitative mass spectrometric proteomics, we identified extensive changes in the levels and phosphorylation states of proteins in HIV-1 infected producer cells upon mixing with CD4+ target cells under conditions inducing VS formation. These coculture-induced alterations involved multiple cellular pathways including transcription, TCR signaling and, unexpectedly, cell cycle regulation, and were dominated by Env-dependent responses. We confirmed the proteomic results using inhibitors targeting regulatory kinases and phosphatases in selected pathways identified by our proteomic analysis. Strikingly, inhibiting the key mitotic regulator Aurora kinase B (AURKB) in HIV-1 infected cells significantly increased HIV activity in cell-to-cell fusion and transmission but had little effect on cell-free infection. Consistent with this, we found that AURKB regulates the fusogenic activity of HIV-1 Env. In the Jurkat T cell line and primary T cells, HIV-1 Env:CD4 interaction also dramatically induced cell cycle-independent AURKB relocalization to the centromere, and this signaling required the long (150 aa) cytoplasmic C-terminal domain (CTD) of Env. These results imply that cytoplasmic/plasma membrane AURKB restricts HIV-1 envelope fusion, and that this restriction is overcome by Env CTD-induced AURKB relocalization. Taken together, our data reveal a new signaling pathway regulating HIV-1 cell-to-cell transmission and potential new avenues for therapeutic intervention through targeting the Env CTD and AURKB activity., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Bruce et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
40. Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.
- Author
-
Belov P, Jakimovski D, Krawiecki J, Magnano C, Hagemeier J, Pelizzari L, Weinstock-Guttman B, and Zivadinov R
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Jugular Veins physiopathology, Male, Middle Aged, Neck blood supply, Phlebography, Carotid Arteries pathology, Jugular Veins pathology, Multiple Sclerosis, Relapsing-Remitting pathology, Vertebral Artery pathology
- Abstract
Background and Purpose: Arterial and neck vessel system characteristics of patients with multiple sclerosis have not been previously investigated. Therefore, the aim of this study was to examine the frequency of neck vessels and their cross-sectional areas (in square millimeters) between patients with MS and healthy controls., Materials and Methods: In this study, 193 patients with MS and 193 age- and sex-matched healthy controls underwent 2D TOF venography at 3T. The main arterial (carotid and vertebral), venous (internal jugular), and secondary neck vessels were examined at 4 separate cervical levels (C2/3, C4, C5/6, and C7/T1). The ANCOVA adjusted for age, body mass index, smoking status, hypertension, and heart disease was used to compare the differences between patients with MS and healthy controls., Results: After controlling for all confounding factors, patients with MS had significantly lower cross-sectional areas of the carotid arteries at the C2/3 ( P = .03), C5/6 ( P = .026), and C7/T1 ( P = .005) levels as well as of the vertebral arteries at the C2/3 ( P = .02), C4 ( P = .012), and C7/T1 ( P = .006) levels, compared with healthy controls. A higher frequency of secondary neck vessels was found at all 4 levels in patients with MS: C2/3 (12.9 versus 10, P < .001), C4 (9.1 versus 7.5, P < .001), C5/6 (7.8 versus 6.8, P = .012), and C7/T1 (8.8 versus 6, P < .001). The total cross-sectional areas of secondary neck vessels were also significantly higher at all 4 levels ( P < .03). No significant differences in the cross-sectional areas of jugular veins were found between patients with MS and healthy controls., Conclusions: Patients with MS showed lower cross-sectional areas of the carotid and vertebral arteries and a higher frequency of secondary neck vessels and their cross-sectional areas compared with healthy controls., (© 2018 by American Journal of Neuroradiology.)
- Published
- 2018
- Full Text
- View/download PDF
41. Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease.
- Author
-
Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C, and Zivadinov R
- Subjects
- Adult, Atrophy, Brain physiopathology, Female, Humans, Jugular Veins physiopathology, Male, Middle Aged, Prospective Studies, Aging, Brain blood supply, Brain diagnostic imaging, Jugular Veins diagnostic imaging, Magnetic Resonance Angiography
- Abstract
Objectives To assess the relationship between cross-sectional area of internal jugular veins and brain volumes in healthy individuals without neurologic disease. Methods A total of 193 healthy individuals without neurologic disease (63 male and 130 female; age > 20 to < 70 years) received magnetic resonance venography and structural brain magnetic resonance imaging at 3T. The internal jugular vein cross-sectional area was assessed at C2-C3, C4, C5-C6, and C7-T1. Normalized whole brain volume was assessed. Partial correlation analyses were used to determine associations. Results There was an inverse relationship between normalized whole brain volume and total internal jugular vein cross-sectional area (C7-T1: males r = -0.346, p = 0.029; females r = -0.301, p = 0.002). After age adjustment, association of normalized whole brain volume and normalized gray matter volume with internal jugular vein cross-sectional area became positive in males (normalized whole brain volume and right internal jugular vein cross-sectional area (C2-C3) changed from r = -0.163 to r = 0.384, p = 0.002), but not in the females. Conclusion Sex differences exist in the relationship between brain volume and internal jugular vein cross-sectional area in healthy individuals without neurologic disease.
- Published
- 2017
- Full Text
- View/download PDF
42. Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
- Author
-
Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM, and Schweser F
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Brain pathology, Case-Control Studies, Cerebral Hemorrhage pathology, Disability Evaluation, Disabled Persons, Disease Susceptibility, Humans, Learning Disabilities etiology, Learning Disabilities pathology, Magnetic Resonance Angiography, Memory Disorders etiology, Memory Disorders pathology, Middle Aged, Multiple Sclerosis pathology, Neuropsychological Tests, Prospective Studies, Young Adult, Cerebral Hemorrhage etiology, Multiple Sclerosis complications
- Abstract
Purpose To assess cerebral microbleed (CMB) prevalence in patients with multiple sclerosis (MS) and clinically isolated syndrome (CIS) and associations with clinical outcomes. Materials and Methods CMBs are associated with aging and neurodegenerative disorders. The prevalence of CMBs has not previously been well established. In this study, 445 patients with MS (266 with relapsing-remitting MS, 138 with secondary progressive MS, and 41 with primary progressive MS), 45 patients with CIS, 51 patients with other neurological diseases, and 177 healthy control subjects (HCs) underwent 3-T magnetic resonance (MR) imaging and clinical examinations. A subset of 168 patients with MS and 50 HCs underwent neuropsychological testing. Number of CMBs was assessed on susceptibility-weighted minimum intensity projections by using the Microbleed Anatomic Rating Scale; volume was calculated by using quantitative susceptibility maps. Differences between groups were analyzed with the χ
2 test, Fisher exact test, Student t test, and analysis of variance; associations of CMBs with clinical and other MR imaging outcomes were explored with correlation and regression analyses. Because CMB frequency increases with age, prevalence was investigated in participants at least 50 years of age and younger than 50 years. Results Significantly more patients with MS than HCs had CMBs (19.8% vs 7.4%, respectively; P = .01) in the group at least 50 years old. A trend toward greater presence of CMBs was found in patients with MS (P = .016) and patients with CIS who were younger than 50 years (P = .039) compared with HCs. In regression analysis adjusted for age, hypertension, and normalized brain volume, increased number of CMBs was significantly associated with increased physical disability in the MS population (R2 = 0.23, P < .0001). In correlation analysis, increased number of CMBs was significantly associated with deteriorated auditory and verbal learning and memory (P = .006) and visual information processing speed trends (P = .049) in patients with MS. Conclusion Monitoring CMBs may be relevant in patients with MS and CIS at higher risk for developing cognitive and physical disability.© RSNA, 2016 Online supplemental material is available for this article.- Published
- 2016
- Full Text
- View/download PDF
43. Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
- Author
-
Beggs CB, Magnano C, Belov P, Krawiecki J, Ramasamy DP, Hagemeier J, and Zivadinov R
- Subjects
- Adult, Female, Healthy Volunteers, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Cerebral Aqueduct pathology, Cerebral Veins pathology, Jugular Veins pathology, Multiple Sclerosis pathology
- Abstract
Objectives: Constricted cerebral venous outflow has been linked with increased cerebrospinal fluid (CSF) pulsatility in the aqueduct of Sylvius in multiple sclerosis (MS) patients and healthy individuals. This study investigates the relationship between CSF pulsatility and internal jugular vein (IJV) cross-sectional area (CSA) in these two groups, something previously unknown., Methods: 65 relapsing-remitting MS patients (50.8% female; mean age = 43.8 years) and 74 healthy controls (HCs) (54.1% female; mean age = 43.9 years) were investigated. CSF flow quantification was performed on cine phase-contrast MRI, while IJV-CSA was calculated using magnetic resonance venography. Statistical analysis involved correlation, and partial least squares correlation analysis (PLSCA)., Results: PLSCA revealed a significant difference (p<0.001; effect size = 1.072) between MS patients and HCs in the positive relationship between CSF pulsatility and IJV-CSA at C5-T1, something not detected at C2-C4. Controlling for age and cardiovascular risk factors, statistical trends were identified in HCs between: increased net positive CSF flow (NPF) and increased IJV-CSA at C5-C6 (left: r = 0.374, p = 0.016; right: r = 0.364, p = 0.019) and C4 (left: r = 0.361, p = 0.020); and increased net negative CSF flow and increased left IJV-CSA at C5-C6 (r = -0.348, p = 0.026) and C4 (r = -0.324, p = 0.039), whereas in MS patients a trend was only identified between increased NPF and increased left IJV-CSA at C5-C6 (r = 0.351, p = 0.021). Overall, correlations were weaker in MS patients (p = 0.015)., Conclusions: In healthy adults, increased CSF pulsatility is associated with increased IJV-CSA in the lower cervix (independent of age and cardiovascular risk factors), suggesting a biomechanical link between the two. This relationship is altered in MS patients.
- Published
- 2016
- Full Text
- View/download PDF
44. Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals.
- Author
-
Magnano C, Belov P, Krawiecki J, Hagemeier J, Beggs C, and Zivadinov R
- Subjects
- Adult, Aged, Anatomy, Cross-Sectional, Female, Humans, Jugular Veins pathology, Magnetic Resonance Angiography, Male, Middle Aged, Sex Factors, Young Adult, Aging, Jugular Veins anatomy & histology
- Abstract
Background: Internal jugular vein (IJV) narrowing has been implicated in central nervous system pathologies, however normal physiological age- and gender-related IJV variance in healthy individuals (HIs) has not been adequately assessed., Objectives: We assessed the relationship between IJV cross-sectional area (CSA) and aging., Materials and Methods: This study involved 193 HIs (63 males and 130 females) who received 2-dimensional magnetic resonance venography at 3T. The minimum CSA of the IJVs at cervical levels C2/C3, C4, C5/C6, and C7/T1 was obtained using a semi-automated contouring-thresholding technique. Subjects were grouped by decade. Pearson and partial correlation (controlled for cardiovascular risk factors, including hypertension, heart disease, smoking and body mass index) and analysis of variance analyses were used, with paired t-tests comparing side differences., Results: Mean right IJV CSA ranges were: in males, 41.6 mm2 (C2/C3) to 82.0 mm2 (C7/T1); in females, 38.0 mm2 (C2/C3) to 62.3 mm2 (C7/T1), while the equivalent left side ranges were: in males, 28.0 mm2 (C2/C3) to 52.2 mm2 (C7/T1); in females, 27.2 mm2 (C2/C3) to 47.8 mm2 (C7/T1). The CSA of the right IJVs was significantly larger (p<0.001) than the left at all cervical levels. Controlling for cardiovascular risk factors, the correlation between age and IJV CSA was more robust in males than in the females for all cervical levels., Conclusions: In HIs age, gender, hand side and cervical location all affect IJV CSA. These findings suggest that any definition of IJV stenosis needs to account for these factors.
- Published
- 2016
- Full Text
- View/download PDF
45. Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease.
- Author
-
Beggs CB, Magnano C, Shepherd SJ, Belov P, Ramasamy DP, Hagemeier J, and Zivadinov R
- Subjects
- Adolescent, Adult, Aged, Brain pathology, Female, Humans, Hypertension pathology, Male, Middle Aged, Risk Factors, White Matter pathology, Young Adult, Brain diagnostic imaging, Cerebrospinal Fluid physiology, Hypertension diagnostic imaging, Magnetic Resonance Imaging methods, White Matter diagnostic imaging
- Abstract
Background and Purpose: Aging of the healthy brain is characterized by focal or nonfocal white matter (WM) signal abnormality (SA) changes, which are typically detected as leukoaraiosis (LA). Hypertension is a risk factor for WM lesion formation. This study investigated whether LA might be associated with increased cerebrospinal fluid (CSF) pulsatility linked to arterial hypertension., Methods: A total of 101 individuals without neurologic diseases (53 females and 48 males) aged between 18 and 75 years underwent 3T brain MRI with cine phase contrast imaging for CSF flow estimation, after providing their informed consent. LA was defined as the presence of focal T2 WM SA changes and/or nonfocal uniform areas of signal increase termed dirty appearing white matter (DAWM). Relevant information relating to cardiovascular risk factors was also collected., Results: When controlled for age and hypertension, significant partial correlations were observed between: DAWM volume and: net negative flow (r = -.294, P = .014); net positive flow (NPF) (r = .406, P = .001); and peak positive velocity (r = .342, P = .004). Multiple linear regression analysis revealed DAWM volume to be significantly correlated with CSF NPF (P = .019) and hypertension (P = .007), whereas T2 WM SA volume was only significantly correlated with age (P = .002). Combined DAWM and T2 WM SA volumes were significantly related with age (P = .001) and CSF peak negative velocity (P = .041)., Conclusions: Rarefaction of WM leading to LA is a multifactorial process, in which formation of DAWM induced by hypertension and increased aqueductal CSF pulsatility, may play a contributory role. These two factors appear to act independently of each other in a process that is independent of age., (Copyright © 2015 by the American Society of Neuroimaging.)
- Published
- 2016
- Full Text
- View/download PDF
46. Quantifying errors in flow measurement using phase contrast magnetic resonance imaging: comparison of several boundary detection methods.
- Author
-
Jiang J, Kokeny P, Ying W, Magnano C, Zivadinov R, and Mark Haacke E
- Subjects
- Algorithms, Blood Flow Velocity, Blood Vessels pathology, Computer Graphics, Computer Simulation, Humans, Models, Theoretical, Phantoms, Imaging, Signal-To-Noise Ratio, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging methods, Microscopy, Phase-Contrast methods
- Abstract
Quantifying flow from phase-contrast MRI (PC-MRI) data requires that the vessels of interest be segmented. The estimate of the vessel area will dictate the type and magnitude of the error sources that affect the flow measurement. These sources of errors are well understood, and mathematical expressions have been derived for them in previous work. However, these expressions contain many parameters that render them difficult to use for making practical error estimates. In this work, some realistic assumptions were made that allow for the simplification of such expressions in order to make them more useful. These simplified expressions were then used to numerically simulate the effect of segmentation accuracy and provide some criteria that if met, would keep errors in flow quantification below 10% or 5%. Four different segmentation methods were used on simulated and phantom MRA data to verify the theoretical results. Numerical simulations showed that including partial volumed edge pixels in vessel segmentation provides less error than missing them. This was verified with MRA simulations, as the best performing segmentation method generally included such pixels. Further, it was found that to obtain a flow error of less than 10% (5%), the vessel should be at least 4 (5) pixels in diameter, have an SNR of at least 10:1 and have a peak velocity to saturation cut-off velocity ratio of at least 5:3., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
47. Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow.
- Author
-
Beggs CB, Magnano C, Shepherd SJ, Marr K, Valnarov V, Hojnacki D, Bergsland N, Belov P, Grisafi S, Dwyer MG, Carl E, Weinstock-Guttman B, and Zivadinov R
- Subjects
- Adult, Aged, Cluster Analysis, Female, Humans, Hydrocephalus, Normal Pressure diagnosis, Lateral Ventricles physiopathology, Male, Middle Aged, Reference Values, Software, Statistics as Topic, Cerebral Aqueduct physiology, Cerebrospinal Fluid physiology, Cerebrovascular Disorders diagnosis, Cerebrovascular Disorders physiopathology, Hydrocephalus, Normal Pressure physiopathology, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging, Cine methods, Multiple Sclerosis diagnosis, Multiple Sclerosis physiopathology, Pulsatile Flow physiology, Ultrasonography, Doppler, Color methods, Ultrasonography, Doppler, Transcranial methods, Venous Insufficiency diagnosis, Venous Insufficiency physiopathology
- Abstract
Purpose: To investigate cerebrospinal fluid (CSF) dynamics in the aqueduct of Sylvius (AoS) in chronic cerebrospinal venous insufficiency (CCSVI)-positive and -negative healthy individuals using cine phase contrast imaging., Materials and Methods: Fifty-one healthy individuals (32 CCSVI-negative and 19 age-matched CCSVI-positive subjects) were examined using Doppler sonography (DS). Diagnosis of CCSVI was established if subjects fulfilled ≥2 venous hemodynamic criteria on DS. CSF flow and velocity measures were quantified using a semiautomated method and compared with clinical and routine 3T MRI outcomes., Results: CCSVI was associated with increased CSF pulsatility in the AoS. Net positive CSF flow was 32% greater in the CCSVI-positive group compared with the CCSVI-negative group (P = 0.008). This was accompanied by a 28% increase in the mean aqueductal characteristic signal (ie, the AoS cross-sectional area over the cardiac cycle) in the CCSVI-positive group compared with the CCSVI-negative group (P = 0.021)., Conclusion: CSF dynamics are altered in CCSVI-positive healthy individuals, as demonstrated by increased pulsatility. This is accompanied by enlargement of the AoS, suggesting that structural changes may be occurring in the brain parenchyma of CCSVI-positive healthy individuals., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
48. Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.
- Author
-
Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, and Zivadinov R
- Subjects
- Adolescent, Adult, Aged, Atrophy pathology, Child, Female, Humans, Male, Middle Aged, Reference Values, Reproducibility of Results, Sensitivity and Specificity, Young Adult, Aging pathology, Algorithms, Brain pathology, Image Interpretation, Computer-Assisted methods, Magnetic Resonance Imaging methods, Neurons pathology
- Abstract
Background and Purpose: It has been demonstrated that increased levels of iron in the brain occur with aging. In this study we investigated the nature of the association between age and SWI-filtered phase values, indicative of iron content, in the subcortical deep gray matter of healthy individuals., Materials and Methods: A total of 210 healthy individuals (men: n = 89, women: n = 121), mean age, 39.8 years (standard deviation = 15.5; range = 6-76 years), were imaged on a 3T scanner. Mean MRI phase, mean phase of low-phase voxels, and normalized volumes were determined for total subcortical deep gray matter, caudate, putamen, globus pallidus, thalamus, pulvinar nucleus, hippocampus, amygdala, nucleus accumbens, red nucleus, and substantia nigra. Linear and nonlinear regression models were used to explore the relationship between phase and volume measures, and aging., Results: Mean phase values of subcortical deep gray matter structures showed a quadratic relationship, with individuals in late middle age (40-59 years) having the lowest mean phase values, followed by a reversal of this trend in the elderly. In contrast, mean phase of low-phase voxel measurements showed strong negative linear relationships with aging. Significantly lower phase values were detected in women compared with men (P < .001), whereas no sex differences were observed for mean phase of low-phase voxels. Normalized volume measurements were also linearly related to aging, and women showed smaller normalized volumes of subcortical deep gray matter structures than men (P < .001). Lower mean phase of low-phase voxels was related to decreased volume measures., Conclusions: A strong association between phase (quadratic effect; phase decreases are followed by increases), mean phase of low-phase voxels (linear effect), volume (linear effect), and age was observed. Low phase was related to brain atrophy.
- Published
- 2013
- Full Text
- View/download PDF
49. Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.
- Author
-
Wack DS, Dwyer MG, Bergsland N, Ramasamy D, Di Perri C, Ranza L, Hussein S, Magnano C, Seals K, and Zivadinov R
- Subjects
- Humans, Observer Variation, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Brain pathology, Image Enhancement methods, Image Interpretation, Computer-Assisted methods, Magnetic Resonance Imaging methods, Multiple Sclerosis pathology, Pattern Recognition, Automated methods
- Abstract
Background: Activity of disease in patients with multiple sclerosis (MS) is monitored by detecting and delineating hyper-intense lesions on MRI scans. The Minimum Area Contour Change (MACC) algorithm has been created with two main goals: a) to improve inter-operator agreement on outlining regions of interest (ROIs) and b) to automatically propagate longitudinal ROIs from the baseline scan to a follow-up scan., Methods: The MACC algorithm first identifies an outer bound for the solution path, forms a high number of iso-contour curves based on equally spaced contour values, and then selects the best contour value to outline the lesion. The MACC software was tested on a set of 17 FLAIR MRI images evaluated by a pair of human experts and a longitudinal dataset of 12 pairs of T2-weighted Fluid Attenuated Inversion Recovery (FLAIR) images that had lesion analysis ROIs drawn by a single expert operator., Results: In the tests where two human experts evaluated the same MRI images, the MACC program demonstrated that it could markedly reduce inter-operator outline error. In the longitudinal part of the study, the MACC program created ROIs on follow-up scans that were in close agreement to the original expert's ROIs. Finally, in a post-hoc analysis of 424 follow-up scans 91% of propagated MACC were accepted by an expert and only 9% of the final accepted ROIS had to be created or edited by the expert., Conclusion: When used with an expert operator's verification of automatically created ROIs, MACC can be used to improve inter- operator agreement and decrease analysis time, which should improve data collected and analyzed in multicenter clinical trials.
- Published
- 2013
- Full Text
- View/download PDF
50. Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study.
- Author
-
Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Beggs C, Salvi F, and Zamboni P
- Subjects
- Adolescent, Adult, Aged, Case-Control Studies, Cerebral Veins pathology, Chronic Disease, Female, Humans, Magnetic Resonance Angiography methods, Male, Middle Aged, Multiple Sclerosis, Relapsing-Remitting complications, Treatment Outcome, Venous Insufficiency complications, Video Recording methods, Young Adult, Angioplasty methods, Cerebral Veins surgery, Cerebrospinal Fluid cytology, Multiple Sclerosis, Relapsing-Remitting pathology, Multiple Sclerosis, Relapsing-Remitting surgery, Venous Insufficiency pathology, Venous Insufficiency surgery
- Abstract
Purpose: To investigate characteristics of cine phase contrast-calculated cerebrospinal fluid (CSF) flow and velocity measures in patients with relapsing-remitting (RR) multiple sclerosis (MS) receiving standard medical treatment who had been diagnosed with chronic cerebrospinal venous insufficiency (CCSVI) and underwent percutaneous transluminal angioplasty (PTA)., Materials and Methods: This case-controlled, magnetic resonance (MR) imaging-blinded study included 15 patients with RR MS who presented with significant stenoses (≥50% lumen reduction on catheter venography) in the azygous or internal jugular veins. Eight patients underwent PTA in addition to medical therapy immediately following baseline assessments (case group) and seven had delayed PTA after 6 months of medical therapy alone (control group). CSF flow and velocity measures were quantified over 32 phases of the cardiac cycle by a semiautomated method. Outcomes were compared between groups at baseline and at 6 and 12 months of the study by mixed-effect model analysis., Results: At baseline, no significant differences in CSF flow or velocity measures were detected between groups. At month 6, significant improvement in flow (P<.001) and velocity (P = .013) outcomes were detected in the immediate versus the delayed group, and persisted to month 12 (P = .001 and P = .021, respectively). Within-group flow comparisons from baseline to follow-up showed a significant increase in the immediate group (P = .033) but a decrease in the delayed group (P = .024). Altered CSF flow and velocity measures were associated with worsening of clinical and MR outcomes in the delayed group., Conclusions: PTA in patients with MS with CCSVI increased CSF flow and decreased CSF velocity, which are indicative of improved venous parenchyma drainage., (Copyright © 2013 SIR. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.